Introduction {#S1}
============

Antimicrobial agents are used in food and medical industries to control hazardous microorganisms. The risk of exposure to these microorganisms is increasing, while their resistance to conventionally used antimicrobials is also on the rise ([@B70]; [@B62]). Additionally, consumers are increasingly avoiding foods containing synthetic antimicrobials and prefer products with clean labels ([@B23]). Driven by these urgencies, investigators are prompted to search for novel, potent, and natural antimicrobials to replace the synthetic ones and combat the emerging resistant microorganisms. Bacteriocins are natural, ribosomally synthesized, occasionally posttranslationally modified antimicrobial peptides produced by bacteria ([@B57]). Among the bacteriocin-producing bacteria, lactic acid bacteria (LAB) are a desirable source of these antimicrobials ([@B66]). Lactic acid bacteria have been used safely for decades to manufacture fermented foods due to their role in flavor and texture development ([@B1]; [@B65]). LAB bacteriocins are potentially promising as a safe and effective alternative to synthetic food preservatives and antibiotics ([@B16]; [@B20]; [@B11]).

Lactic acid bacteria bacteriocins have been grouped into three classes: (I) \<5-kDa, lanthionine-containing peptides, often referred to as lantibiotics; (II) \<10-kDa non-lanthionine-containing peptides; and (III) large bacteriolysins ([@B53]). The lantibiotics group has been classified further, according to the biosynthetic pathway, into four classes ([@B74]; [@B68]). Class I lantibiotics are modified by LanB (dehydratase) and LanC (cyclase) enzymes. Class II represents lantibiotics that are modified by LanM, a bifunctional single enzyme with both dehydratase and cyclase activity. Class III lantibiotics are modified by the single enzyme, LanKC, whereas class IV lantibiotics members are modified by LanL. Nisin, a classic example of LAB lantibiotics, has been used as a food preservative ([@B21]), but resistance of foodborne pathogens to the bacteriocin has been reported ([@B46]; [@B44]). Advantages such as structural stability, low cytotoxicity, and broad spectrum of activity sustained the search for new lantibiotics ([@B5]; [@B48]; [@B60]).

Besides the classic culture-based and chromatographic techniques, genome mining has been used recently to predict bacteriocin-related sequences ([@B50]; [@B5]; [@B63]). The combination of microbiological, proteomic, and genomic analyses is a promising approach to facilitate and speed up the discovery of novel bacteriocins. Genome-guided mass spectrometry (MS) can be defined as mass spectrometric analysis conducted based on the information obtained from genomic analysis with the goal of expediting the discovery of new antimicrobial peptides ([@B69]). Implementing this approach, the current investigation led to the discovery of a new bacteriocinogenic strain, *Lactobacillus paraplantarum* OSY-TC318, and its novel lantibiotic, paraplantaricin TC318. The genome of the bacterium was demarked among closely related strains using comparative genome analysis. A genome-guided mass spectrometric analysis was utilized to rapidly reveal the structure of paraplantaricin TC318. To the best of our knowledge, paraplantaricin TC318 is a novel member of class I lantibiotics, and the bacteriocin is potentially useful in food or medical applications.

Materials and Methods {#S2}
=====================

Screening Foods for Antimicrobial-Producing Bacteria {#S2.SS1}
----------------------------------------------------

Thirty-three food products were purchased from grocery stores in the United States and Turkey. These included dairy products (kefir, cheddar, blue, Roquefort, and fermented Turkish cheeses), herbs (thyme and mint), spices (cumin, black pepper, red pepper, and spices mix), meat products (Italian salami, fermented sausage, ground meat, and a Turkish sausage known as sucuk), fermented soybean, kimchi, and Turkish beverages (Boza, Salgam, and pickle juice). Food samples (10 g each) were homogenized in 90 ml of 0.1% sterile peptone water using a homogenizer. Tenfold serial dilutions were made from the homogenate, using the same diluent, and a 100-μl aliquot from each dilution was spread onto plate count agar (PCA), de Man, Rogosa and Sharpe (MRS) agar, and potato dextrose agar (PDA) (Oxoid, Thermo Fisher Scientific, Waltham, MA, United States). For aerobic mesophilic bacteria, the inoculated PCA plates were incubated aerobically at 30°C for 72 h. For LAB isolation, the inoculated MRS plates were incubated anaerobically at 30°C for 48 h. For the isolation of yeasts and molds, the inoculated PDA plates were incubated aerobically at 25°C for 5 days. Morphologically different colonies, on incubated plates, were isolated by streaking on the corresponding agar media. Several hundreds of isolates were screened for their ability to produce antimicrobial agents using the soft-agar overlay technique ([@B28]), with modifications. Briefly, the isolates were inoculated onto MRS agar or tryptic soy agar (TSA; Becton Dickinson, Sparks, MD, United States) and the plates were incubated at 30°C for 24 h. The incubated plates were then overlaid with soft agar media that had been pre-inoculated with *Pediococcus pentosaceus*, *Listeria innocua* ATCC 33090, or *Escherichia coli* K-12, as the indicator bacteria. The soft agar medium was Luria--Bertani broth (Difco, Franklin Lakes, NJ, United States) or MRS broth, both supplemented with 0.75% agar (Thermo Fisher Scientific, St. Louis, MO, United States) and 0.06% CaCO~3~ for neutralizing the acid produced by LAB. After incubation at 30°C for 24 h, the overlaid plates were inspected for inhibition of the indicator strains. Colonies responsible for the inhibition of the indicators were isolated and analyzed further.

Bacterial Strains and Media {#S2.SS2}
---------------------------

The producer strain, OSY-TC318, was streaked on MRS agar, and its overnight subculture in MRS broth was mixed in 80% sterile glycerol in a 1:1 ratio and stocked at −80°C in the food microbiology laboratory culture collection, The Ohio State University (OSU; Columbus, OH, United States). Selected bacterial strains ([Table 1](#T1){ref-type="table"}) were cultivated in MRS broth or TSB to test the spectrum of the antimicrobial agent produced by OSY-TC318.

###### 

Bacteria tested sensitive^*a*^ to *Lactobacillus paraplantarum* OSY-TC318 crude extract.

  Tested bacteria                                Diameter of inhibitory area (mm)^*b*^
  ---------------------------------------------- ---------------------------------------
  **Gram-positive (non-spore former)**           
  *Enterococcus faecalis* OSU 48                 17
  *Listeria monocytogenes* California            16
  *L. monocytogenes* Ohio (nisin resistant)      15
  *L. monocytogenes* OSY-8517                    16
  *L. monocytogenes* Scott A                     16
  *L. monocytogenes* V7                          16.5
  *Listeria innocua*                             13
  *Micrococcus luteus*                           25
  *Staphylococcus aureus* ATCC 25923             15
  *S. aureus* ATCC 29213                         11
  *S. aureus* ATCC 6538                          14
  *S. aureus* OSU 150                            13
  *Staphylococcus epidermidis* 838               11
  *Streptococcus agalactiae*                     21
  **Gram-positive (spore former)**               
  *Bacillus cereus* ATCC 11778                   15
  *B. cereus* ATCC 12826                         16
  *B. cereus* ATCC 14579                         14
  *B. cereus* ATCC 49064                         16
  *B. cereus* ATCC 33019                         12
  *Bacillus subtilis* (tetracycline-resistant)   20
  **Gram-negative**                              
  *Enterobacter aerogenes*                       12
  *Enterobacter liquefaciens*                    14
  *Escherichia coli* K12                         14
  *Proteus vulgaris*                             15
  *Salmonella enterica* ser. Typhimurium         10
  *Yersinia enterocolitica*                      16.5

a

Sensitivity was measured as the visible inhibition of growth during the bioassay, as described in the "Materials and Methods" section.

b

Diameter represents the sum of zone of inhibition and well width; the latter is 7 mm.

Determination of the Antimicrobial Spectrum of OSY-TC318 Cellular Crude Extract {#S2.SS3}
-------------------------------------------------------------------------------

Preliminary data showed that the OSY-TC318 strain produces an antimicrobial agent when grown on MRS agar plates, but not in MRS broth. Therefore, the OSY-TC318 strain overnight culture in MRS broth was spread-plated onto 300 MRS agar plates, 100 μl culture per plate, followed by incubation at 30°C for 72 h. After incubation, OSY-TC318 cells were harvested using a microscopic slide and the harvested cells mixed with 70% isopropanol in a 1:4 (*w*/*v*) ratio for extracting the antimicrobial agent. After shaking at 200 rpm and 25°C for 3 h, the mixture was centrifuged at 7,710 × *g* for 15 min to remove cell debris. The isopropanol in the extract was evaporated using a vacuum concentrator (Speed-Vac; Savant SPD131DDA, Thermo Fisher Scientific). A bioassay technique was used to determine the antimicrobial activity in the concentrated suspension (crude extract) using the agar well diffusion method ([@B4]) against selected strains ([Table 1](#T1){ref-type="table"}) as indicators. Briefly, aliquots (10 μl) of the overnight indicator bacterium were transferred into 10 ml of sterile molten soft agar (0.75% agar) of the MRS broth or TSB. The mixture was poured onto a basal TSA agar plate. After the soft agar solidified, wells were made using the wide end of a sterile pipette and 80-μl aliquots of the crude extracts were dispensed in the agar wells. After incubation at 30°C or 37°C overnight, the plates were inspected for the presence of clear inhibitory zones around the wells.

Testing OSY-TC318 Cellular Crude Extract Against *Clostridium sporogenes* Spores {#S2.SS4}
--------------------------------------------------------------------------------

*Clostridium sporogenes* ATCC 7955 spore suspension was prepared as follows. Stock culture of the bacterium was inoculated in freshly prepared reinforced clostridial medium (RCM) broth and incubated anaerobically at 37°C for 3 days. The resulting culture was streaked on RCM agar and incubated as previously described. Colonies from the RCM agar were transferred to 100 ml of Duncan--Strong sporulation medium, modified for *Clostridium perfringens* ([@B56]), followed by anaerobic incubation at 30°C for 7 days. After incubation, the spore-containing medium was centrifuged at 5,857 × *g* for 10 min. The spore pellet was resuspended in 25 ml sterile water followed by a heat shock at 80°C for 25 min. The suspension was re-centrifuged at 5,857 × *g* for 10 min followed by resuspension in 25 ml phosphate-buffered saline (137 mmol/l NaCl, 2.7 mmol/l KCl, 10 mmol/l Na~2~HPO~4~/KH~2~PO~4~, pH 7.4) containing 0.5 mg/ml lysozyme (Sigma-Aldrich, St. Louis, MO, United States). The suspension was incubated at 37°C for 2 h and centrifuged again at 2,510 × *g* for 20 min. The pellet was washed with sterile water and centrifuged at 2,510 × *g* for 20 min, followed by resuspension in sterile water. This final *C. sporogenes* spore suspension contained 7.6 × 10^6^ spore-forming units (SFU)/ml, as counted on RCM agar. The antimicrobial activity of the OSY-TC318 crude extract against *C. sporogenes* spores was determined in sterile polymerase chain reaction (PCR) tubes. Briefly, each tube contained 178 μl freshly prepared RCM broth, 20 μl *C. sporogenes* spore suspension (final concentration at 10^4^ SFU/ml), and 2 μl crude extract. The antimicrobial activity was indicated by observing no turbidity after anaerobic incubation at 37°C for 18 h.

Identification of the OSY-TC318 Strain Using 16S rDNA Sequencing {#S2.SS5}
----------------------------------------------------------------

The 16S ribosomal RNA (rRNA) gene (16S rDNA) was sequenced to identify the producer isolate, OSY-TC318, as previously described ([@B72]; [@B75]), with modifications. A single colony of strain OSY-TC318 was cultured in MRS broth at 30°C for 18 h. Aliquot (1 ml) of the broth culture was centrifuged at 16,000 × *g* for 2 min. The supernatant was discarded and 180 μl lysis buffer containing 20 mg lysozyme (Sigma-Aldrich) per milliliter nuclease-free water (Qiagen, Hilden, Germany) was used to resuspend the cell pellet, followed by incubation at 37°C for 2 h. The genomic DNA in the lysed OSY-TC318 cells was extracted and purified using a commercial kit (DNeasy blood and tissue kit; Qiagen, Valencia, CA, United States), following the manufacturer's protocol. Universal primers, specific for amplifying bacterial 16S rDNA (forward primer: 5′-CCGAATTCGTCGACAACAGAGTTTGATCCTGGCTCAG-3′; reverse primer: 5′-CCCGGGATCCAAGCTTAAGGAGGTG ATCCAGCC-3′) were used in the PCR. The sequence within the 16S rDNA was amplified using DNA polymerase (MyTaq, Bioline, Taunton, MA, United States) under the following thermocycler conditions: (i) an initial incubation at 95°C for 3 min; (ii) 35 cycles of denaturation at 95°C for 15 s, annealing at 52°C for 1 min, and extension at 72°C for 30 s; and (iii) a final extension step at 72°C for 10 min. The PCR product was purified using a commercial DNA purification kit (QIAquick gel extraction kit; Qiagen) following the manufacturer's instructions. The purified PCR product was sequenced at the OSU Nucleic Acid Shared Resource facility (Columbus, OH, United States). The resulting 16S rDNA sequence was compared to known sequences in the National Center for Biotechnology Information (NCBI) database using Basic Local Alignment Search Tool-Nucleic Acids (BLAST-N; [@B9]).

Identification of the OSY-TC318 Strain Using MALDI-TOF MS {#S2.SS6}
---------------------------------------------------------

Identity of the antimicrobial producer, OSY-TC318, was determined at the OSU Medical Center (Columbus, OH, United States) using a matrix-assisted laser desorption/ionization--time of flight mass spectrometry (MALDI-TOF MS) biotyper (Bruker Biotyper; Bruker Daltonics, Billerica, MA, United States) as previously described ([@B8]), with modifications. Before the analysis, OSY-TC318 was streaked onto MRS agar and incubated at 30°C for 48 h to obtain well-isolated colonies. The biotyper was calibrated using a bacterial test standard, *E. coli* DH5 alpha (BTS, Bruker Daltonics). A working matrix solution was made of 250 μl standard solvent (50% acetonitrile, 47.5% water, and 2.5% trifluoroacetic acid) and 2.5 mg α-cyano-4-hydroxycinnamic acid crystals (HCCA, Bruker Daltonics). This mixture was vortexed until the crystals were dissolved. Using a wooden toothpick, a single colony was spotted on a clean MBT Biotarget 96-well plate (Bruker Daltonics) and allowed to dry. One microliter of the working matrix solution was added onto the spotted well and allowed to dry. The 96-well plate was loaded into the mass spectrometer (Bruker MicroFlex LT; Bruker Daltonics). Spectra were collected following the method supplied by the equipment's manufacturer. For the spectral analysis and isolate identification, the biotyper software (MTB Compass 4.1; Bruker Daltonics) was used to match the spectrum of the isolate against the MALDI-TOF MS Bruker library following Bruker's recommended parameters. Scores between 1.70 and 1.99 were considered appropriate for genus-level identification and those ≥2.0 were considered candidates for species-level identification. Three independent experiments were done to confirm the identity of the antimicrobial-producing bacterium, OSY-TC318.

Genome-Based Taxonomy of the OSY-TC318 Strain {#S2.SS7}
---------------------------------------------

The genome of OSY-TC318 was sequenced previously and the draft genome sequence was deposited in the GenBank database under accession number [SEHH00000000.1](SEHH00000000.1) ([@B33]). For the purpose of accurately classifying the OSY-TC318 strain and exploring its phylogenetic relationship with closely related strains, the following genomic analysis was executed. A genomic-based comparison was conducted between the OSY-TC318 draft genome and 11 publicly accessible genomes, announced as *L. paraplantarum*, in the NCBI genome database ([Table 2](#T2){ref-type="table"}). The Genome Taxonomy Database Toolkit (GTDB-Tk v1.0.2) was used for assigning a taxonomic classification for the 12 investigated genomes, including OSY-TC318, based on: a) placement in a domain-specific reference tree representing 23,471 bacterial genomes and b) calculating their average nucleotide identity (ANI) to a reference genome considering 95% ANI as a species circumscription radius ([@B13]; [@B51]). In the 12 query genomes, GTDB-Tk identified genes using a prokaryotic dynamic programming gene-finding algorithm, PRODIGAL v2.6.2 ([@B35]). Out of these genes, 120 bacterial marker genes, encoding ubiquitous single-copy proteins, were identified and aligned using the profile hidden Markov models (profile HMMs) search tool, HMMER v3.1 ([@B24]; [@B52]), for phylogenetic inference. From the concatenated multiple sequence alignment of the marker genes, the phylogenetic placement tool pplacer v1.1 ([@B43]) was used for maximum-likelihood placement of the query genomes into the GTDB-Tk reference tree. Finally, GTDB validated the species assignment by calculating the ANI of the query genomes, based on *L. paraplantarum* DSM 10667 (GCA_001435655.1) as a GTDB species representative, using the ANI determination tool FastANI v2.0 ([@B37]). For data visualization, a phylogenetic sub-tree which contains the query genomes was isolated from the GTDB-Tk reference tree and viewed using the phylogenetic trees visualization and manipulation tool (Interactive Tree Of Life, iTOL, v4) ([@B41]). AnnoTree v1.2, a tool used for the visualization of genome annotations across large phylogenetic trees, was used to locate *L. paraplantarum* across 27,000 bacterial genomes phylogenetic trees, derived from the GTDB database ([@B45]). Additionally, the query genomes were compared visually against the OSY-TC318 genome based on the genomic sequence alignment using the BLAST ring image generator, BRIG ([@B2]).

###### 

Genomic features and average nucleotide identity (ANI) of *Lactobacillus paraplantarum* genomes, including OSY-TC318 (this study), when compared against *L. paraplantarum* DSM 10667 (GCF_001435655.1) as a reference genome.

  NCBI^*a*^ strain identifiers   Source                            Assembly accession                   Genome size (Mb)   GC%    Genes   Proteins   ANI%
  ------------------------------ --------------------------------- ------------------------------------ ------------------ ------ ------- ---------- -------------------
  DSM 10667                      Beer contaminant, France          [GCA_001435655.1](GCA_001435655.1)   3.39575            43.7   3,280   3,094      100
  NBRC 107151                    Beer contaminant, France          [GCA_007991915.1](GCA_007991915.1)   3.33087            43.7   3,246   3,072      99.99
  DSM 10667                      Beer contaminant, France          [GCA_003641145.1](GCA_003641145.1)   3.36853            43.9   3,328   3,098      99.94
  AS-7                           Fruits and vegetables, Pakistan   [GCA_003045685.1](GCA_003045685.1)   3.00744            44.1   2,890   2,730      99.94
  AY01                           Ewes milk, China                  [GCA_000469115.1](GCA_000469115.1)   3.31597            43.7   3,202   3,021      99.73
  D2-1                           Unknown                           [GCA_002897175.1](GCA_002897175.1)   3.52146            43.6   3,531   3,275      99.57
  Lp109                          Cured beef, China                 [GCA_003609655.1](GCA_003609655.1)   3.38074            43.7   3,372   3,120      99.54
  OSY-TC318                      Cheese, Turkey                    [GCA_004330485.1](GCA_004330485.1)   3.58749            43.4   3,474   2,846      98.23
  L-ZS9                          Fermented meat, China             [GCA_001443645.1](GCA_001443645.1)   3.13973            44.0   2,990   2,792      97.66
  L-ZS9                          Fermented meat, China             [GCA_000758145.1](GCA_000758145.1)   3.11972            43.9   2,947   2,807      97.64
  KMB-599                        Sheep milk, Slovakia              [GCA_003346405.1](GCA_003346405.1)   3.17349            43.9   3,058   2,865      97.59
  CRL 1905                       Quinoa sourdough, Argentina       [GCA_001660655.1](GCA_001660655.1)   1.80977            44.7   1,681   1,622      Not applicable^a^

a

NCBI, National Center for Biotechnology Information.

b

See text for detailed explanation.

Mining the Genomes of OSY-TC318 and Closely Related Strains for Bacteriocin Sequences {#S2.SS8}
-------------------------------------------------------------------------------------

Considering the relatedness between OSY-TC318 and the 11 *L. paraplantarum* strains, genomes of the 12 strains were mined for genes related to bacteriocin biosynthesis using the antibiotics and secondary metabolite analysis shell software antiSMASH v4.1.0 ([@B7]) and the web-based bacteriocin genome mining tool BAGEL v4.0 ([@B71]). After identifying a putative novel lantibiotic gene cluster uniquely in the OSY-TC318 draft genome, NCBI-BLASTP was used to align the cluster genes with related sequences in the NCBI database ([@B9]) for their function prediction. Knowing the potential functions of the cluster genes has led to the prediction of the putative lantibiotic, designated paraplantaricin TC318, amino acid sequence, and its biosynthetic pathway. The theoretical molecular mass of the lantibiotic was calculated from its predicted amino acid sequence using the proteomics analysis tool Protein Prospector v5.22.0 ([@B40]).

Liquid Chromatographic Purification of Paraplantaricin TC318 and Analysis Using MALDI-TOF MS {#S2.SS9}
--------------------------------------------------------------------------------------------

A high-performance liquid chromatography (HPLC) system (Hewlett Packard 1050, Agilent Technologies, Palo Alto, CA, United States) was used to purify the antimicrobial agent produced by the OSY-TC318 strain from its cellular crude extract. The stationary phase was a reversed-phase C~18~ column (Discovery BIO C~18~ column, 25 cm × 4.6 mm I.D., 5 μm, Supelco, Bellefonte, PA, United States). The mobile phase consisted of (A) acetonitrile with 0.1% trifluoroacetic acid (TFA) and (B) HPLC-grade water with 0.1% TFA. For each run, aliquots (100) of the crude extract were loaded and separated on the column by a linear gradient of solvent A from 0 to 100% over 30 min followed by 100% solvent A for 5 min at a flow rate of 1.0 ml/min. Elution was monitored using a UV detector at a wavelength of 220 nm. Fractions were collected at a rate of one fraction per minute (Fraction Collector II; Waters Cooperation, Milford, MA, United States). Fractions with the same retention time from multiple runs were combined and dried using a vacuum concentrator (Speed-Vac). The resulting dry fractions were dissolved in 70% acetonitrile and the antimicrobial activity of each fraction was tested against *P. pentosaceus* as an indicator. When spotted on the surface of the inoculated soft agar plate, the solvent (70% acetonitrile), which dissipated quickly, did not show antimicrobial activity against the indicator bacterium after overnight incubation. The multiple HPLC run fractions, containing the semi-purified antimicrobial agent, were further purified by re-injection into the HPLC using the same conditions described previously. To confirm that the antimicrobial activity is caused by the putative lantibiotic, paraplantaricin TC318, active fractions were initially analyzed using a MALDI-TOF/TOF mass spectrometer (UltrafleXtreme; Bruker Daltonics), operated in reflection positive ion mode, at the Campus Chemical Instrument Center (CCIC), OSU (Columbus, Ohio, United States). The matrix was HCCA (Bruker Daltonics) which was dissolved in acetonitrile with 0.1% TFA in water (1:1, *v*/*v*) to obtain a saturated matrix solution. The HPLC fractions with antimicrobial activity were mixed with the matrix in a ratio of 1:5 (*v*/*v*). One microliter of the previous mixture was spotted on the MALDI stainless steel plate. The spectral masses, in the range of *m*/*z* 500--5,000, were detected. A neodymium-doped yttrium aluminum garnet laser (Yag/Nd laser), at 351 nm, was set at 5% higher than the threshold level to minimize fragmentation. The mass spectrometer was calibrated using a peptide calibration standard (Standard II; Bruker Daltonics). The spectra were analyzed using commercial analysis software (Flex; Bruker Daltonics). The HPLC fractions that showed a peak with an average mass congruent to the calculated mass of paraplantaricin TC318 were selected for accurate mass determination during subsequent analysis.

FT-ICR-MS Analysis {#S2.SS10}
------------------

Accurate mass determination and sequencing of paraplantaricin TC318 required analysis by Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS). Active, concentrated, and pure HPLC fractions containing paraplantaricin TC318 were subjected to FT-ICR-MS analysis (Bruker 15 Tesla solariXR FT-ICR mass spectrometer; Bruker Daltonics) at CCIC, OSU (Columbus, OH, United States). The spectrometer, coupled with a MALDI or electron spray ionization (ESI) source, was used with a 4M transient that provided the required resolution for accurate mass measurement (\<1 ppm error). The MALDI source was used for the purpose of determining the accurate mass of the singly charged ions and for peptide sequencing, whereas the ESI source was used for determining the accurate mass of the doubly charged ions. For MALDI analysis, the samples were mixed with the HCCA MALDI matrix solution in a ratio of 1:5 (*v*/*v*) and 1 μl of the mixture was spotted on the MALDI stainless steel plate. The mass spectrometer was calibrated using a peptide calibration standard (Bruker Daltonics). A neodymium-doped yttrium aluminum garnet laser (Yag/Nd, 351 nm) was used for ionization with varying laser powers of 20--25% to ionize/desorb the peptide ions. Ions were detected in the range of *m*/*z* 500--4,000. Additional quadrupole collision-induced dissociation (QCID) MS/MS analysis was performed at 80-eV collision energy (with a collision gas of argon) and 40% laser power to fragment the singly charged peptide and obtain its amino acid sequence. For the ESI source, the original HPLC fractions were diluted 10-fold in a solvent made of water and acetonitrile, at a 1:1 ratio, and containing 0.1% TFA. The diluted solution was sprayed using standard ESI conditions (ESI spray voltage = 4,500 V, capillary voltage = 250 V, capillary temperature = 180°C, and flow rate = 2.5 μl/min).

Results {#S3}
=======

Isolation of Antimicrobial-Producing Strain and the Inhibition Spectrum of Its Cellular Crude Extract {#S3.SS1}
-----------------------------------------------------------------------------------------------------

Several hundred isolates, obtained from 33 food products, were screened for their antimicrobial activity; among these, a few isolates showed antimicrobial activity. A Turkish cheese isolate, designated OSY-TC318, showed strong inhibition against the indicator bacterium, *P. pentosaceus*. Subsequently, OSY-TC318 was subjected to further analyses to determine its identity and characterize potential antimicrobial agents. The OSY-TC318 cell-free crude extract showed a wide range of antimicrobial activity when tested against selected bacterial pathogenic and spoilage strains such as *Bacillus cereus*, *Enterococcus faecalis*, *Listeria monocytogenes*, *Salmonella* Typhimurium, and *Staphylococcus aureus* ([Table 1](#T1){ref-type="table"}). Importantly, the OSY-TC318 cell-free crude extract inhibited the germination or outgrowth of *C. sporogenes* spores; therefore, the strain OSY-TC318 was selected for comprehensive genomic and proteomic analyses.

Comparing 16S rDNA Sequencing and MALDI-TOF MS Biotyping as Methods for Rapid Identification of OSY-TC318 Isolate {#S3.SS2}
-----------------------------------------------------------------------------------------------------------------

Due to the promising antimicrobial potential of OSY-TC318, its identity was investigated using multiple approaches. Sequencing the 16S rRNA gene of the OSY-TC318 strain resulted in 95% identity with *Lactobacillus plantarum* strains SM2, gp106, and gp108 and also 95% identity with *L. paraplantarum* strains JCM12533, MRS8, and FH3. Based on these results, it was concluded that the 16S rDNA sequencing approach was insufficient for the accurate identification of the OSY-TC318 strain. Using MALDI-TOF MS-based biotyping, it was found that the OSY-TC318 spectrum had a first-best match with *L. paraplantarum* with a score of 2.24; the second-best match was *L. plantarum* with score of 2.17. Therefore, OSY-TC318 was preliminary identified as *L. paraplantarum*. However, genomic analysis was required for the accurate taxonomic classification of the OSY-TC318 strain and for distinguishing it among closely related strains of *L. paraplantarum*.

Genome-Based Taxonomy of OSY-TC318 and Its Demarcation Among Closely Related Strains Using Comparative Genomic Analysis {#S3.SS3}
-----------------------------------------------------------------------------------------------------------------------

Using comparative genomic approach, the OSY-TC318 strain along with 10 other known *L. paraplantarum* genomes were classified, based on placement in the GDTB reference tree ([Figures 1A,B](#F1){ref-type="fig"}) and ANI% ([Table 2](#T2){ref-type="table"}), as *L. paraplantarum*. In addition to its phylogeny, GTDB-Tk revealed that *L. paraplantarum* OSY-TC318 has an ANI of 98.23% with *L. paraplantarum* DSM 10667 (GCF_001435655.1). Although the CRL 1905 genome is announced on NCBI as *L. paraplantarum*, GTDB taxonomy assigned CRL 1905 to the genus *Lactobacillus* based on the topological placement and showed that it has an ANI of 98.65% with *Lactobacillus rhamanosus* DSM 20021(GCA_000615245.1). When aligning OSY-TC318 with the queried genomes, the blank spaces represent the genomic regions with 0% identity ([Figure 1C](#F1){ref-type="fig"}); this shows how different this newly discovered strain is from other *L. paraplantarum* strains. The phylogeny, the ANI, and the genomic sequence alignment analyses confirmed the identity of *L. paraplantarum* OSY-TC318 and also distinguished it from the previously announced *L. paraplantarum* genomes. One of the most important distinguishing features was the presence of a unique lantibiotic gene cluster in *L. paraplantarum* OSY-TC318, as will be described later.

![Phylogenetic relationship and genomic-based comparison between *Lactobacillus paraplantarum* OSY-TC318 and closely related genomes. **(A)** Placement of *L. paraplantarum* OSY-TC318 in a phylogenetic tree that represents 27,000 bacterial genomes. **(B)** Placement of *L. paraplantarum* OSY-TC318 among closely related genomes of the species. **(C)** BLAST Ring Image Generator (BRIG) diagram comparing 11 query genomes, announced as *L. paraplantarum* on NCBI, with OSY-TC318 considered as a reference genome. In the BRIG diagram **(C)**, *L. paraplantarum* genomes are arranged from *inner* to *outer circle* as follows: OSY-TC318, DSM_10667_1, NBRC_107151, DSM_10667_2, AS_7, AY01, D2_1, Lp109, L_ZS9_1, L_ZS9_2, KMB_599, and CRL_1905. Genomic regions with 0% identity with the reference genome are indicated as *blank spaces*.](fmicb-11-01381-g001){#F1}

Genome Mining for Bacteriocin Sequences and the Analysis of a Novel Lantibiotic Biosynthetic Gene Cluster {#S3.SS4}
---------------------------------------------------------------------------------------------------------

A comparative genome mining for bacteriocin sequences in *L. paraplantarum* OSY-TC318 and the other 11 closely related genomes revealed several plantaricin genetic clusters in all the investigated genomes. Common plantaricin genetic clusters *(pln)* detected were *plnABCD*, *plnJKLR*, and *plnEFI*. Importantly and uniquely, a type I lantibiotic biosynthetic gene cluster was detected in the *L. paraplantarum* OSY-TC318 genome. The identified biosynthetic cluster of the putative lantibiotic, paraplantaricin TC318, comprised 11 open reading frames (ORFs). The proposed function of each ORF, length, closest homolog, percent identity, and the percent query coverage are shown in [Table 3](#T3){ref-type="table"}. The paraplantaricin TC318 biosynthetic gene cluster includes the prepropeptide structural gene (*lanA*), modification enzyme genes (*lanB*, *lanC*, and *lanD*), a protease enzyme gene (*lanP*), three secretion ABC-type transporter and self-immunity genes (*lanT1*, *lanT2*, and *lanT3*), two regulatory genes (*lanK* and *lanR*), and a gene with an unknown function ([Figure 2A](#F2){ref-type="fig"}).

###### 

Open reading frame (ORF) analysis of the putative paraplantaricin TC318 biosynthetic gene cluster and flanking genes.

  ORF no.   Proposed function                                Length (amino acids)   GenBank accession number; closest homolog (NCBI database accessed on 7/11/2018)                                Percent identity (percent query cover)
  --------- ------------------------------------------------ ---------------------- -------------------------------------------------------------------------------------------------------------- ----------------------------------------
  1         No function determined                           101                    [WP_063487862.1](WP_063487862.1), hypothetical protein \[*Lactobacillus plantarum*\]                           93 (91)
  2         LanK (sensor histidine kinase)                   327                    [WP_062688923.1](WP_062688923.1), sensor histidine kinase \[*Lactobacillus plantarum*\]                        99 (100)
  3         LanR (transcriptional regulatory protein)        225                    [WP_062688921.1](WP_062688921.1), DNA-binding response regulator \[*Lactobacillus plantarum*\]                 100 (100)
  4         LanT1 (ABC transporter ATP-binding protein)      547                    [WP_062688919.1](WP_062688919.1), ABC transporter ATP-binding protein \[*Lactobacillus plantarum*\]            100 (100)
  5         LanP (leader peptide processing protease)        461                    [WP_032531395.1](WP_032531395.1), peptidase S8 lantibiotic specific protease\[*Streptococcus mutans*\]         44 (97)
  6         LanD (decarboxylation enzyme)                    186                    [WP_002304546.1](WP_002304546.1), Lantibiotic biosynthesis protein \[*Streptococcus mutans*\]                  49 (94)
  7         LanC (lanthionine synthetase C family protein)   437                    [WP_002289980.1](WP_002289980.1), lantibiotic epidermin biosynthesis protein EpiC \[*Streptococcus mutans*\]   99 (100)
  8         LanB (lantibiotic dehydratase domain protein)    1,005                  AAG48566.1, *MutB \[Streptococcus mutans*\]                                                                    32 (98)
  9         LanA (prepropeptide of TC318)                    62                     [WP_002268802.1](WP_002268802.1), gallidermin/nisin family lantibiotic \[*Streptococcus mutans*\]              57 (87)
  10        No function determined                           114                    [WP_062688908.1](WP_062688908.1), hypothetical protein \[*Lactobacillus plantarum*\]                           100 (100)
  11        LanT2 (ABC transporter, ATP-binding protein)     649                    [WP_062688906.1](WP_062688906.1), ABC transporter permease \[*Lactobacillus plantarum*\]                       99 (100)
  12        LanT3 (ABC transporter, ATP-binding protein)     246                    [WP_062688904.1](WP_062688904.1), ABC transporter ATP-binding protein \[*Lactobacillus plantarum*\]            100 (100)
  13        Tra1 (transposase)                               95                     [ERO39513.1](ERO39513.1), putative transposase \[*Lactobacillus plantarum* WJL\]                               74 (100)
  14        Tra2 (transposase)                               76                     [WP_076644604.1](WP_076644604.1), transposase \[*Lactobacillus plantarum*\]                                    93 (100)
  15        Tra3 (transposase)                               139                    [WP_016527020.1](WP_016527020.1), transposase \[*Lactobacillus plantarum*\]                                    90 (97)

![Bioinformatics analysis of the novel lantibiotic paraplantaricin TC318. **(A)** Genetic organization of paraplantaricin TC318 biosynthetic gene cluster. **(B)** Primary sequence alignment of lantibiotic TC318 amino acid residues with the sequences of mutacin 1140, mutacin B-Ny266, mutacin I gallidermin, and epidermin using ClustalW tool (<http://www.ebi.ac.uk/tools/clustalw2>). Mutacin 1140 is the most related lantibiotic to TC318.](fmicb-11-01381-g002){#F2}

The proposed paraplantaricin TC318 biosynthetic mechanism ([Figure 3](#F3){ref-type="fig"}) starts with the expression of the structural gene to make the prepropeptide. The prepropeptide consists of a propeptide at the C-terminus and a leader peptide at the N-terminus. Some of the proposed functions of the leader peptide are signaling for peptide export and serving as a scaffold for assisting posttranslational modifications, including the cleavage of the prepropeptide by a peptidase ([@B12]; [@B36]). The specific posttranslational modifications of paraplantaricin TC318 are introduced by enzymes encoded in the biosynthetic gene cluster. Based on the sequencing of this biosynthetic gene cluster, it can be inferred that these enzymes catalyze the dehydration (Lan B) and cyclization (Lan C) of the serine and threonine residues in the propeptide that can condense with the neighboring cysteine residue, leading to the formation of lanthionine and methyllanthionine (thioether) bridges, respectively. The enzyme encoded by *lanD* may catalyze the decarboxylation of the C-terminal cysteine residue, forming the C-terminal S-\[(*Z*)-2-aminovinyl\]-[D]{.smallcaps}-cysteine (AviCys) residue ([@B12]). After the dehydration and the cyclization, the leader peptide is removed by the protease as the last step in the biosynthesis ([@B59]). Based on the genomic analysis, the predicted amino acid sequence of paraplantaricin TC318 consisted of 22 residues that differ from the mutacin 1140 sequence by four amino acids ([Figures 2B](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). The predicted chemical formula of paraplantaricin TC318 is C~106~H~133~N~27~O~22~S~4~, which corresponds to a monoisotopic neutral molecular mass of 2,263.900 Da.

![Proposed posttranslational modifications and structure of paraplantaricin TC318. TC318 contains four thioether rings (A--D). *Dha*, dehydroalanine; *Dhb*, dehdrobutyrine.](fmicb-11-01381-g003){#F3}

Purification of Paraplantaricin TC318 and Structural Elucidation Using FT-ICR-MS {#S3.SS5}
--------------------------------------------------------------------------------

To verify the predicted structure of the lantibiotic produced by *L. paraplantarum* OSY-TC318, the compound was separated and purified using reversed-phase HPLC. During a 30-min HPLC run of 0--100% acetonitrile gradient, the active antimicrobial agent was eluted at a retention time of 17.8 min, which was detected using the antimicrobial activity assay of eluted fractions. A representative HPLC chromatograph of the crude extract and the corresponding active fraction is presented in [Figure 4](#F4){ref-type="fig"}. For accurate mass determination, the purified HPLC fraction was analyzed using FT-ICR-MS, coupled with a MALDI or ESI source. When a MALDI source was used, the results showed peaks of the singly charged ions (\[M + H\]^+^, \[M + O\]^+^, and \[M + Na\]^+^) of the intact paraplantaricin TC318, with *m*/*z* values of 2,264.90718, 2,280.90219, and 2,286.88937, respectively ([Figure 5](#F5){ref-type="fig"}). Therefore, the accurate monoisotopic mass of the paraplantaricin TC318 singly charged ion, \[M + H\]^+^, is *m*/z 2,264.90718, a value that matched the previously calculated theoretical molecular mass of 2,263.900, after subtracting the hydrogen ion, with 0.1 ppm error. Using the ESI source, the FT-ICR-MS results showed a doubly charged paraplantaricin TC318 (\[M + 2H\]^2+^) with an accurate *m*/*z* of 1,132.95792; this matched the corresponding theoretical calculated *m*/*z* of 1,132.957343 with 0.5 ppm error, as shown in [Figure 6](#F6){ref-type="fig"}.

![Purification of paraplantaricin TC318 from crude extract using liquid chromatography. *Red arrow* indicates the single peak showing antimicrobial activity against an indicator strain, *Pediococcus pentosaceus*.](fmicb-11-01381-g004){#F4}

![Fourier transform ion cyclotron resonance mass spectrometry/matrix-assisted laser desorption/ionization (FT-ICR-MS/MALDI) analysis of the singly charged ions (\[M + H\]^+^, \[M + O\]^+^, and \[M + Na\]^+^) from intact paraplantaricin TC318 with the observed *m*/*z* of 2,264.90718, 2,280.90219, and 2,286.88937, respectively.](fmicb-11-01381-g005){#F5}

![Fourier transform ion cyclotron resonance mass spectrometry/electron spray ionization (FT-ICR-MS/ESI) analysis of paraplantaricin TC318 doubly charged ion (\[M + 2H\]^2+^) with an observed *m*/*z* of 1,132.95792.](fmicb-11-01381-g006){#F6}

For paraplantaricin TC318 sequencing, the precursor peak of the peptide singly charged ion, \[M + H\]^+^, was isolated and fragmented using QCID MS/MS analysis. As shown in [Supplementary Table S1](#TS1){ref-type="supplementary-material"} and [Supplementary Figure S1](#TS1){ref-type="supplementary-material"}, a series of MS/MS product ions were observed which matched the predicted structure based on the genomic analysis, as shown in [Figure 3](#F3){ref-type="fig"} and [Supplementary Figure S2](#TS1){ref-type="supplementary-material"}. Therefore, the biosynthetic pathway and the structure of the new paraplantaricin TC318 lantibiotic were confirmed based on the genomic analysis combined with MS analysis. However, the thioether ring structure made it difficult for complete fragmentation by QCID.

Discussion {#S4}
==========

The discovery of a new beneficial antimicrobial agent is a tedious and time-consuming task, a fact consistent with the experience of the investigators of the current study ([@B29]; [@B28]; [@B75]). The urgency to speed up the discovery of new antimicrobials prompted these investigators to benefit from the advances in genomic and mass spectrometric analyses to accomplish this goal. The efficient approach implemented in this study led to the discovery of paraplantaricin TC318 from a LAB isolated from cheese. Successful discovery of a new antimicrobial agent not only involves its characterization and structural elucidation but also requires accurate identification of the producer. Considering that antimicrobial production is rare within a given species and is highly strain-dependent, it is critical to identify the producer to the infraspecies level. The following discussion illustrates the approach followed in this study for identifying the antimicrobial-producing isolate to the stain level.

Lactic acid bacteria include many genera, with *Lactobacillus* encompassing the largest group of species that have many applications in food and human health industries ([@B27]; [@B47]). Despite the commercial value of LAB as dairy starters and probiotics, the use of inaccurate identification methods, such as those based on phenotypic traits, has led to mislabeled strains in scientific publications, publicly available genetic sequences, and commercial products ([@B34]; [@B32]). Molecular methods have been developed and used for LAB identification, with 16S rRNA gene sequencing as the most common ([@B15]). Results of the 16S rRNA gene sequencing for species of the *L. plantarum* group (*L. plantarum*, *L. paraplantarum*, *Lactobacillus fabifermentans*, and *Lactobacillus pentosus*) may show 99% similarity, making it difficult to discriminate among these species using this method ([@B67]; [@B31]). Moreover, using the 16S rRNA gene or any other single phylogenetic marker gene is inadequate to obtain accurate phylogenetic relationships ([@B52]).

Sequencing the 16S rRNA gene was inadequate to accurately identify OSY-TC318; the results showed that it has the same identity percentage with both *L. plantarum* and *L. paraplantarum*. Biotyping with MALDI-TOF MS is a simple, rapid, and relatively inexpensive method that can be used to identify bacteria based on the mass spectra of highly abundant ribosomal proteins ([@B26]). Using this method, the OSY-TC318 isolate was identified as *L. paraplantarum*. Currently, whole-genome sequencing is considered an official source for taxonomic information ([@B73]). In the current study, genome-based taxonomy was used to assign the taxon *L. paraplantarum* to the OSY-TC318 isolate. Comparative genomics, including phylogenetic relationship analysis, ANI calculation, and visualization of the genomic sequence alignments, made it possible to distinguish the genome *L. paraplantarum* OSY-TC318 from 10 closely related genomes and to exclude the *L. paraplantarum* CRL 1905 genome from this group. The constructed phylogeny was based on the concatenation of 120 ubiquitous bacterial single-copy proteins to obtain a higher taxonomic resolution superior to that obtained from the 16S rRNA gene sequence ([@B52]). These analyses revealed the novelty of *L. paraplantarum* OSY-TC318 and demarked it among closely related strains.

The discovery of new antimicrobial agents, particularly bacteriocin, is a tedious and time-consuming task particularly when a culture-based screening approach is followed. The task is hampered further by the lack of knowledge about the specific conditions or triggers required for the bacteriocin expression, such as nutrients, pH, and temperature ([@B76]). Additional complications result from the scarcity of bacteriocin production by the producer strain ([@B60]) and the necessity of identifying the chemical structure of the putative antimicrobial compound to exclude the unspecific antimicrobial agents and assure the novelty of the investigated bacteriocin ([@B48]). Recently, the emergence of genome mining tools has expanded the knowledge about bacteriocins and their biosynthetic mechanisms ([@B61]); however, verification using culture techniques and proteomic analysis is still needed to validate the genomic analysis output and to confirm the putative bacteriocin expression and biological activity ([@B17]). Therefore, an efficient combination of culture-based, genomic, and proteomic analyses is required for a time-saving bacteriocin discovery. In the current study, we conducted a genome-guided MS approach that led to elucidating the structure and characterizing the biosynthetic mechanism of paraplantaricin TC318.

In addition to the structural gene (*lanA*), the lantibiotic operon also includes protein-encoding genes that carry out the posttranslational modification (*lanB*, *lanC*, *lanM*, *lanKC*, or *lanL*), the proteolytic processing for cleaving the leader sequence (*lanP*), transportation of the propeptide (*lanT*), and the immunity (*lanI* and *lanFEG*) ([@B6]; [@B25]; [@B55]). Mining of the bacteriocin sequences was conducted not only in the OSY-TC318 genome but also in the 11 related *L. paraplantarum* genomes. Various *pln* operons associated with *L. plantarum*, including *plnABCD*, *plnJKLR*, and *plnEFI*, were found in all the query genomes ([@B22]; [@B39]; [@B42]; [@B58]). Additionally, a unique class I lantibiotic biosynthetic gene cluster was identified in the *L. paraplantarum* OSY-TC318 genome. The cluster includes *lanA*, *lanB*, *lanC*, and *lanD*, three *lanT*, *lanP*, *lanK*, and *lanR* ([Figure 2B](#F2){ref-type="fig"}). [@B10] suggested that the ability of lantibiotic production is dispersed among Gram-positive bacteria by the transfer of lantibiotic-encoding mobile elements such as plasmids or transposons. The presence of transposase genes *tra1*, *tra2*, and *tra3* adjacent to the biosynthetic gene cluster of paraplantaricin TC318 ([Figure 2B](#F2){ref-type="fig"}) suggests that its genetic code may have originated from an ancestral transposon ([@B14]).

The analysis of the propeptide sequence showed that mutacin 1140, a member of the epidermin group in class I lantibiotic, is the most closely related to paraplantaricin TC318 as both share 18 of their 22 amino acids. The epidermin group is characterized by the presence of one dehdrobutyrine (Dhb), one methyllanthionine, and two lanthionine residues besides the unusual ring structure containing S-\[(*Z*)-2-aminovinyl\]-[D]{.smallcaps}-cysteine (AviCys; [@B12]). Besides mutacin 1140, gallidermin, mutacin B-Ny266, and mutacin I are other natural variants to epidermin which share the four thioether bridges. Epidermin was isolated from *Staphylococcus epidermidis* Tü 3298 ([@B3]) and gallidermin was isolated from *Staphylococcus gallinarum* Tü 3928 ([@B38]). Mutacin 1140, mutacin B-Ny266, and mutacin I were isolated from *Streptococcus mutans* JH1140, Ny266, and CH43, respectively ([@B49]; [@B54]; [@B64]). To the best of our knowledge, the current study is the first report of a mutacin variant produced by a *Lactobacillus* sp.

*L. paraplantarum* OSY-TC318 produced paraplantaricin TC318 in solid media only. A similar behavior was observed in mutacin 1140, which was explained by the inhibition of structural gene transcription by the mature lantibiotic. [@B30] hypothesized that growing the producer on a solid medium allows the diffusion of the lantibiotic away from the inoculated cells and increases the synthesis time before reaching an inhibitory concentration. To produce the paraplantaricin TC318 crude extract, producer cells were grown and harvested from MRS agar plates followed by extraction using 70% isopropanol. Bacteriocins have antagonistic activity against bacteria of the same species, thus exhibiting a narrow spectrum or, across several genera, exerting a broad spectrum ([@B19]). The antimicrobial spectrum of the cell-free crude extract, containing paraplantaricin TC318, showed that it has a wide range of activity against pathogenic and spoilage bacteria ([Table 1](#T1){ref-type="table"}).

The FT-ICR-MS analysis was executed to elucidate the structure of the purified paraplantaricin TC318, and the results strongly supported the structure predicted by genomic analysis. The paraplantaricin TC318 propeptide consists of 22 amino acids (Phe-Lys-Dha-Trp-Dha-Leu-Cys-Dhb-Phe-Gly-Cys-Gly-His-Dhb-Gly-Dha-Phe-Asn-Dha-Phe-Cys-Cys), as shown in [Figure 3](#F3){ref-type="fig"}. The proposed structure of paraplantaricin TC318 includes four thioether rings, and this makes it resemble members of class I lantibiotics. The thioether ring contains a single sulfur atom and links two amino acids through their β-carbons. The fragmentation was achieved between the rings during the FT-ICR-MS analysis. Despite the lack of complete fragmentation, the chemical formula, the calculated mass, and the observed mass of the fragments confirmed the structure of the rings. In future studies, nuclear magnetic resonance spectroscopic analysis could help in revealing the complete chemical structure of the new lantibiotic compound. Further analyses are planned to determine paraplantaricin TC318's tertiary structure, mode of action, cytotoxic effect on mammalian cells, and its applicability in various products.

In conclusion, genomic and proteomic analyses were efficiently combined to identify accurately the new *L. paraplantarum* OSY-TC318 strain and to elucidate the structure of its novel lantibiotic, paraplantaricin TC318. The antimicrobial activity of the paraplantaricin TC318 crude extract against a wide range of pathogenic and spoilage bacteria supports its potential usefulness in food and medical applications.
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